NCT02387723View on ClinicalTrials.gov

CSCC_ASC Therapy in Patients With Severe Heart Failure

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

December 31, 2014

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Heart Failure
Interventions
BIOLOGICAL

Allogeneic adipose derived stem cells (CSCC_ASC)

Culture expanded allogeneic adipose derive stem cells (CSCC\_ASC)

Trial Locations (1)

2100

2014 Department of Cardiology, The Heart Centre, University Hospital Rigshospitalet, Copenhagen

All Listed Sponsors
lead

JKastrup

OTHER

NCT02387723 - CSCC_ASC Therapy in Patients With Severe Heart Failure | Biotech Hunter | Biotech Hunter